Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with certain advanced or spreading cancers, confirmed by laboratory testing of tissue — these cancers include melanoma, breast cancer that no longer responds to hormone treatment, kidney cancer, bladder cancer, head and neck cancer, or non-small cell lung cancer (including some cases suitable for surgery)
- People who are willing and able to follow the study requirements as set out in the protocol
- People who have a stored tumour tissue sample (a type called FFPE) available for research testing
- People aged between 18 and 90 years old at the time of joining
- People whose general physical functioning falls within an acceptable range, as measured by a standard medical scale (ECOG score of 2 or below — confirm with trial site what this means for individual circumstances)
- People who are able to understand and sign an informed consent form
- People who agree to take part in a survey about social, economic, and psychological factors
Who may not be able to join:
- People with a known history of HIV infection
- People with serious neurological or psychiatric conditions
- People who are pregnant or currently breastfeeding
- People who are unable or unwilling to provide written informed consent
- People who are unable or unwilling to attend regular follow-up appointments at the same trial centre
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Licia Rivoltini, Fondazione IRCCS Istituto Nazionale Tumori - Milan
Phone: +3902/23903245
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Immunological endpoint; Immunological endpoint; Immunological endpoint; Immunological endpoint; Clinical endpoint_PFS; Clinical endpoint_OS; Clinical endpoint_ORR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.